Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

REGENEUS LTD

INVESTOR PRESENTATION - REGENEUS LTD

ASX:RGS

REGENEUS LTD

Health Care

Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Read more

Market Cap

43.54m

Price at Close

$0.145

4w avg. Volume

179.72k

4w avg. Turnover

$27.27k

Announcements
announcementt+2 movementdate
  • Results of Annual General Meeting

    Notice Of Meeting

  • -6.25%

    14 Oct 2020

-6.25%

14 Oct 2020
  • AGM Chairman's Address and CEO Presentation

    Chairman's Address

  • -6.25%

    14 Oct 2020

-6.25%

14 Oct 2020
  • Regeneus to be granted new Sygenus patent in Canada

    Progress Report · Market sensitive

  • 0.00%

    06 Oct 2020

0.00%

06 Oct 2020
  • Australian Biomarker Patent Allowed

    Progress Report

  • -6.45%

    30 Sep 2020

-6.45%

30 Sep 2020
  • Regeneus receives $676k in R&D Tax Incentives

    Periodic Reports

  • 0.00%

    28 Sep 2020

0.00%

28 Sep 2020
  • Notice of initial substantial holder - AGC Inc.

    Shareholder Details

  • +8.33%

    11 Sep 2020

+8.33%

11 Sep 2020
  • Virtual Annual General Meeting Online Guide

    Notice Of Meeting

  • +14.29%

    10 Sep 2020

+14.29%

10 Sep 2020
  • Notice of Annual General Meeting / Proxy / Question Form

    Notice Of Meeting

  • +14.29%

    10 Sep 2020

+14.29%

10 Sep 2020
  • Issue of AGC shares complete

    Issued Capital

  • +14.29%

    10 Sep 2020

+14.29%

10 Sep 2020
  • Appendix 2A

    Issued Capital

  • +14.29%

    10 Sep 2020

+14.29%

10 Sep 2020
Market Data

Current Price

$0.145

52WK HIGH

$0.2

52WK LOW

$0.049

1YR RETURN

+90.79%

1YR RETURN VS. SECTOR

+67.34%

90 DAY RETURN

+66.67%

ASX RANK

1,122

/2,010

SECTOR RANK

28

/47

SHARES OUTSTANDING

300.28m
ASX:RGS

REGENEUS LTD

Health Care

Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Read more

Market Cap

43.54m

Price at Close

$0.145

4w avg. Volume

179.72k

4w avg. Turnover

$27.27k

ASX:RGS is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.